Table 1.
Baseline characteristics of patients
| Median age (range) | 53 (34–71) | ||
|---|---|---|---|
| Sex | |||
| Female | 12 (92 %) | ||
| Male | 1 (8 %) | ||
| ECOG* | |||
| 0 | 8 (62 %) | ||
| 1 | 5 (39 %) | ||
| Cancer | |||
| Breast cancer | 4 (31 %) | ||
| Ovarian cancer | 2 (15 %) | ||
| Endometrial cancer | 1 (8 %) | ||
| Colon cancer | 2 (15 %) | ||
| Rectal cancer | 1 (8 %) | ||
| Gastric cancer | 1 (8 %) | ||
| Gallbladder cancer | 1 (8 %) | ||
| NSCLC | 1 (8 %) | ||
| Line of treatment for TAS-117 | |||
| 2 | 1 (8 %) | ||
| 3 | 2 (15 %) | ||
| 4 | 6 (46 %) | ||
| 5 | 2 (15 %) | ||
| 6 | 1 (8 %) | ||
| 9 | 1 (8 %) | ||
| Royal Marsden Score | |||
| 0 | 1 (8 %) | ||
| 1 | 5 (38 %) | ||
| 2 | 6 (46 %) | ||
| 3 | 1 (8 %) | ||
| GRIm-Score | |||
| 0 | 6 (46 %) | ||
| 1 | 5 (38 %) | ||
| 2 | 1 (8 %) | ||
| 3 | 1 (8 %) | ||
| Number of metastatic organs | |||
| 1 | 1 (8 %) | ||
| 2 | 6 (46 %) | ||
| 3 | 4 (31 %) | ||
| 5 | 2 (15 %) | ||
Abbreviations: ECOG, Eastern Cooperative Oncology Group; GRIm-Score, Gustave Roussy Immune Score
*An ECOG performance status score 0 means that the patient is fully active and 1 means that the patient is restricted in physically strenuous activity but ambulatory